Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Wen Y. Chen0
Thomas E. Wagner0
Date of Patent
April 10, 2007
Patent Application Number
09815306
Date Filed
March 23, 2001
Patent Primary Examiner
Patent abstract
A novel fusion protein, comprising a receptor-antagonizing domain and a positive immunomodulator domain, characterized, for example, by its ability to block apoptosis and/or inhibit endocrine response, is useful in treating cancer. For example, a human prolactin antagonist-interleukin 2 (hPRLA-IL-2) fusion protein combines apoptosis induction and immuno-therapy to combat cancer in the breast or prostate.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
